Preclinical Efficacy Studies Of Ds-1062a, A Novel Trop2-Targeting Antibody-Drug Conjugate With A Novel Dna Topoisomerase I Inhibitor Dxd.

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 15|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要